Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Diabetes Cure Moves a Step Closer with new Hadassah/Hebrew University Research


Hope for a future cure of insulin-dependent (type 1) diabetes received a boost from the research findings of a multi-year project led by Prof. Yuval Dor of Hebrew University's Institute for Medical Research Israel-Canada with Hadassah University Medical Center's co-lead author Prof. Benjamin Glaser and his research team, who identified the key signal that initiates production of insulin-producing beta cells in the pancreas. (Read the full story in the September 11 Jerusalem Post article.)

Date: 10/24/2011

More hMedicine Stories

Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America